The latest news from academia, regulators
research labs and other things of interest
Posted: March 18, 2009
Arrowhead Management to Present Objectives for 2009 Via Webcast
(Nanowerk News) Arrowhead Research Corporation announced today that Dr. Christopher Anzalone, Arrowhead’s Chief Executive Officer and President, will present the Company’s strategic plan and objectives for 2009 at 10:30 a.m. PT on March 26, 2009, following the scheduled Annual Meeting of Shareholders (“the Meeting”).
The presentation, followed by a question and answer period, will be webcast live beginning at 10:30 a.m. PT. Audio and video replay will be available approximately three hours after the conclusion of the Meeting for those unable to attend the live webcast. Information on how to access the webcast will be posted on Arrowhead’s website by Monday, March 23 at http://arrowres.com/meeting2009.html.
The Company also announced that it had withdrawn two proposals – Proposal 3 and Proposal 4 – contained in its 2009 Notice and Proxy Statement, filed with the SEC on February 18, 2009, from consideration for approval at its 2009 Meeting. The Proposals sought to amend the Company’s 2004 Equity Incentive Plan to allow a one-time option repricing program, without further stockholder approval. The Proposals were withdrawn following further deliberation by the Company’s Board of Directors, management and with shareholders.
About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com) is a nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is seeking to build value for shareholders through the progress of majority owned subsidiaries. Currently, Arrowhead has four subsidiaries commercializing nanotech products and applications and minority investments in two privately held nanobiotech companies.
Source: Arrowhead Research Corporation (press release)